Jiangsu Kanion Pharmaceutical Co., Ltd
14
0
0
7
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
0.0%
0 terminated/withdrawn out of 14 trials
100.0%
+13.5% vs industry average
43%
6 trials in Phase 3/4
14%
1 of 7 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (14)
Study of Compound Nanxing Zhitong Ointment in the Treatment of Chronic Pain in Musculoskeletal System
Role: lead
Effect of KYG0395 on Primary Dysmenorrhea
Role: lead
A Clinical Study on the Efficacy and Safety of Reduning Injection in the Treatment of Chikungunya Fever
Role: lead
A Phase I Clinical Trial Evaluating the Safety, Tolerability and Pharmacokinetics of AAPB for Injection
Role: lead
A Prospective Cohort Study of Compound Nanxing Zhitong Ointment
Role: lead
Evaluate the Safety, Tolerability and Pharmacokinetic Profile of TPN672 Tablets Maleate in Patients With Schizophrenia
Role: lead
Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke
Role: collaborator
A Randomized, Placebo-Controlled, Double-blind Study of Tianshu Capsule in the Treatment of Migraine.
Role: lead
A Safety Study of Ginkgolides Meglumine Injection in the Treatment of Ischemic Stroke.
Role: lead
A Pilot Study for Ginkgolides Meglumine Injection Skin Testing.
Role: lead
Multi-center Clinical Trials of Sanjie Analgesic Capsule in Treating Endometriosis
Role: lead
A Drug-Drug Interaction Study To Investigate The Ginkgolides Meglumine Injection To Alter The Pharmacokinetics Of Midazolam
Role: lead
Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection.
Role: lead
A Clinical Trial To Evaluate Reduning Injection in the Treatment of Mild Type of Hand, Foot, and Mouth Disease
Role: lead
All 14 trials loaded